Stay updated on ILIxadencel + CPI in Tumors Clinical Trial
Sign up to get notified when there's something new on the ILIxadencel + CPI in Tumors Clinical Trial page.

Latest updates to the ILIxadencel + CPI in Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page; no other content or functional changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1, with no changes to study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedMinor UI and metadata updates were made: glossary toggle options (Show glossary / Hide glossary), capitalization tweaks in QC-related text (Last Update Submitted that Met QC Criteria vs Last Update Submitted that met QC Criteria), and a new revision tag (Revision: v3.4.0) with related wording changes (No FEAR Act Data vs No FEAR Act data). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedRevision: v3.3.4 is displayed on the page, replacing v3.3.3. This is a minor version update with no changes to the trial details.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now includes a dedicated Locations section listing Florida, Iowa, Kentucky, North Carolina, and Ohio. The HHS Vulnerability Disclosure link and the former state-specific location sections were removed, and the revision tag was updated to v3.3.3.SummaryDifference0.6%

- Check92 days agoChange DetectedThe page revision updated from v3.2.0 to v3.3.2; no user-visible content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ILIxadencel + CPI in Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ILIxadencel + CPI in Tumors Clinical Trial page.